Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Tvardi Therapeutics, Inc. (TVRD) had Return on Equity of -19.83% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-5.53M |
|
-- |
|
-- |
|
$5.94M |
|
$-5.94M |
|
$0.41M |
|
$-5.53M |
|
$-5.53M |
|
$-5.53M |
|
$-5.53M |
|
$-5.53M |
|
$-5.53M |
|
$-5.94M |
|
$-5.91M |
|
9.38M |
|
9.38M |
|
$-0.59 |
|
$-0.59 |
|
| Balance Sheet Financials | |
$38.44M |
|
$0.06M |
|
$0.58M |
|
$39.02M |
|
$11.04M |
|
-- |
|
$0.12M |
|
$11.15M |
|
$27.87M |
|
$27.53M |
|
$27.87M |
|
9.38M |
|
| Cash Flow Statement Financials | |
$-17.81M |
|
$-15.08M |
|
$22.70M |
|
$31.61M |
|
$21.42M |
|
$-10.20M |
|
$1.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-19.83% |
-20.08% |
|
-14.16% |
|
-19.83% |
|
$2.97 |
|
$-1.90 |
|
$-1.90 |
|